Cargando…

Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost

BACKGROUND: In comparison to the conventional whole-prostate dose escalation, an integrated boost to the macroscopic malignant lesion might potentially improve tumor control rates without increasing toxicity. Quality of life after radiotherapy (RT) with vs. without (18)F-choline PET-CT detected simu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinkawa, Michael, Piroth, Marc D, Holy, Richard, Klotz, Jens, Djukic, Victoria, Escobar Corral, Nuria, Caffaro, Mariana, Winz, Oliver H, Krohn, Thomas, Mottaghy, Felix M, Eble, Michael J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299580/ https://www.ncbi.nlm.nih.gov/pubmed/22289620 http://dx.doi.org/10.1186/1748-717X-7-14

Ejemplares similares

Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy
por: Pinkawa, Michael, et al.
Publicado: (2012)

Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume
por: Piroth, Marc D., et al.
Publicado: (2016)

Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer - predictive factors on irritative symptoms, incontinence and rectal bleeding
por: Pinkawa, Michael, et al.
Publicado: (2009)

Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme - a dosimetric comparison
por: Piroth, Marc D, et al.
Publicado: (2009)

Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study
por: Pinkawa, Michael, et al.
Publicado: (2010)

Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy – a retrospective analysis
por: Piroth, Marc D, et al.
Publicado: (2008)

Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study
por: Gagel, Bernd, et al.
Publicado: (2007)

Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment
por: Pinkawa, Michael, et al.
Publicado: (2009)

Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost
por: Embring, Anna, et al.
Publicado: (2023)

Dose-escalated Radiotherapy with Simultaneous Integrated Boost for Bone Metastases in Selected Patients with Assumed Favourable Prognosis
por: Potkrajcic, Vlatko, et al.
Publicado: (2022)

Partially ablative radiotherapy (PAR) for large mass tumors using simultaneous integrated boost: A dose‐escalation feasibility study
por: Cilla, Savino, et al.
Publicado: (2018)

Quality of life more than 10 years after radiotherapy for localized prostate cancer—impact of time after treatment and prescription dose
por: Pinkawa, Michael, et al.
Publicado: (2020)

Combined PET Imaging and Diffusion-Weighted Imaging of Intermediate and High-Risk Primary Prostate Carcinomas with Simultaneous [(18)F] Choline PET/MRI
por: Wetter, Axel, et al.
Publicado: (2014)

[(18)F] fluoromisonidazole and [(18)F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study
por: Gagel, Bernd, et al.
Publicado: (2006)

Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous (18)F-choline PET/MRI for prostate cancer
por: Muehlematter, Urs J., et al.
Publicado: (2018)

Choline PET/CT in Multiple Myeloma
por: Mesguich, Charles, et al.
Publicado: (2020)

Plasma Kinetics of Choline and Choline Metabolites After A Single Dose of SuperbaBoost(TM) Krill Oil or Choline Bitartrate in Healthy Volunteers
por: Mödinger, Yvonne, et al.
Publicado: (2019)

Correction to: impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous (18)F-choline PET/MRI for prostate cancer
por: Muehlematter, Urs J., et al.
Publicado: (2018)

Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer – focus on overall survival
por: Freiberger, Carla, et al.
Publicado: (2017)

COVID-19 pneumonia: increased choline uptake with 18F-choline PET/CT
por: Olivari, Laura, et al.
Publicado: (2020)

A Dosimetric Comparison of Dose Escalation with Simultaneous Integrated Boost for Locally Advanced Non-Small-Cell Lung Cancer
por: Yang, Wenjuan, et al.
Publicado: (2017)

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
por: Zhang, Qin, et al.
Publicado: (2022)

Dose‐escalated simultaneously integrated boost radiation protocol fails to result in a survival advantage for sinonasal tumors in dogs
por: Meier, Valeria, et al.
Publicado: (2022)

Simultaneous Integrated Boost for Dose Escalation in Node-Positive Cervical Cancer: 5-Year Experience in a Single Institution
por: Cheung, Elki Sze-Nga, et al.
Publicado: (2023)

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
por: Schwarzenböck, S., et al.
Publicado: (2012)

Sodium [(18)F]Fluoride PET Can Efficiently Monitor In Vivo Atherosclerotic Plaque Calcification Progression and Treatment
por: Florea, Alexandru, et al.
Publicado: (2021)

Boosting the acceptance of (18)F-FET PET for image-guided treatment planning with a multi-centric prospective trial
por: Langen, Karl-Josef, et al.
Publicado: (2023)

Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gastrointestinal organs remain critical
por: Stefanowicz, Sarah, et al.
Publicado: (2020)

Short-course PET based simultaneous integrated boost for locally advanced cervical cancer
por: Arnesen, Marius Røthe, et al.
Publicado: (2016)

Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts
por: Goodman, Christopher D., et al.
Publicado: (2019)

Gastrointestinal Quality-of-Life Trajectories after Radiotherapy for Prostate Cancer—Which Patients Suffer from Persisting Problems?
por: Pinkawa, Michael
Publicado: (2023)

Dose escalated simultaneous integrated boost of gross nodal disease in gynecologic cancers: a multi-institutional retrospective analysis and review of the literature
por: Jensen, Garrett Lee, et al.
Publicado: (2021)

IMAT-IGRT Treatment with Simultaneous Integrated Boost as Dose Escalation for Patients with Cervical Cancer: A Single Institution, Prospective Pilot Study
por: Lőcsei, Zoltán, et al.
Publicado: (2021)

Interdisciplinary consensus statement on indication and application of a hydrogel spacer for prostate radiotherapy based on experience in more than 250 patients
por: Müller, Arndt-Christian, et al.
Publicado: (2016)

Escalation of radiotherapy dose in large locally advanced drug-resistant gastrointestinal stromal tumors by multi-shell simultaneous integrated boost intensity-modulated technique: a feasibility study
por: Cui, Haixia, et al.
Publicado: (2022)

Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques
por: Aly, Moamen M.O.M., et al.
Publicado: (2015)

An imaging evaluation of the simultaneously integrated boost breast radiotherapy technique
por: Turley, Jessica, et al.
Publicado: (2015)

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
por: Thureau, Sébastien, et al.
Publicado: (2018)

Usefulness of Choline-PET for the detection of residual hemangiopericytoma in the skull base: comparison with FDG-PET
por: Ito, Shin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j4lca3idh9q2rh8j4fq0oijk9m